pregabalin intas pregabalin 75 mg capsules bottle pack
accord healthcare pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: gelatin; purified water; sodium lauryl sulfate; titanium dioxide; pregelatinised maize starch; iron oxide red; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pregabalin intas (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin intas (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
pregabalin intas pregabalin 300 mg capsules bottle pack
accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; sodium lauryl sulfate; purified talc; purified water; pregelatinised maize starch; iron oxide red; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pregabalin intas (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin intas (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
pregabalin taro 100 mg
taro international ltd, israel - pregabalin - capsules - pregabalin 100 mg - pregabalin - pregabalin taro is indicated for the: • treatment of peripheral and central neuropathic pain in adults. • management of fibromyalgia. • treatment of generalised anxiety disorder (gad) in adults.
pregabalin taro 150 mg
taro international ltd, israel - pregabalin - capsules - pregabalin 150 mg - pregabalin - pregabalin taro is indicated for the: • treatment of peripheral and central neuropathic pain in adults. • management of fibromyalgia. • treatment of generalised anxiety disorder (gad) in adults.
pregabalin taro 200 mg
taro international ltd, israel - pregabalin - capsules - pregabalin 200 mg - pregabalin - pregabalin taro is indicated for the: • treatment of peripheral and central neuropathic pain in adults. • management of fibromyalgia. • treatment of generalised anxiety disorder (gad) in adults.
pregabalin taro 225 mg
taro international ltd, israel - pregabalin - capsules - pregabalin 225 mg - pregabalin - pregabalin taro is indicated for the: • treatment of peripheral and central neuropathic pain in adults. • management of fibromyalgia. • treatment of generalised anxiety disorder (gad) in adults.
pregabalin taro 300 mg
taro international ltd, israel - pregabalin - capsules - pregabalin 300 mg - pregabalin - pregabalin taro is indicated for the: • treatment of peripheral and central neuropathic pain in adults. • management of fibromyalgia. • treatment of generalised anxiety disorder (gad) in adults.
pregabalin taro 75 mg
taro international ltd, israel - pregabalin - capsules - pregabalin 75 mg - pregabalin - pregabalin taro is indicated for the: • treatment of peripheral and central neuropathic pain in adults. • management of fibromyalgia. • treatment of generalised anxiety disorder (gad) in adults.
pregabalin-drla pregabalin 25 mg capsule blister pack
dr reddys laboratories australia pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: purified talc; titanium dioxide; sodium lauryl sulfate; lactose monohydrate; gelatin; purified water; maize starch - pregabalin-drla (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin-drla (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
pregabalin-drla pregabalin 75 mg capsule blister pack
dr reddys laboratories australia pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: iron oxide red; gelatin; lactose monohydrate; titanium dioxide; maize starch; sodium lauryl sulfate; purified water; purified talc - pregabalin-drla (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin-drla (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.